EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Dynamic FIB-4 trajectory and a multi-state Markov model analysis reveal fibrosis progression and cardiovascular-cerebrovascular risk in MAFLD patients

Xin-Yu Fu, Si-Yan Yan, Ya-Qi Song, Ya-Fei Ye, Jia-Li Ma, Ling-Ling Yan, Jia-Wei Liang, Shan-Jing Xu, Shi-Wen Xu, Ya-Hong Chen, Xin-Li Mao, Shao-Wei Li

Nutrition, Metabolism and Cardiovascular Diseases · 2026

DOI: 10.1016/j.numecd.2026.104617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2026. Verfasst von Xin-Yu Fu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Taizhou Hospital of Zhejiang Province, Linhai, Zhejiang, China; Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Liver Cirrhosis, Cardiovascular Diseases, Non-alcoholic Fatty Liver Disease, Cerebrovascular Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Plan Project of Taizhou, Medical Science and Technology Project of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIM: Metabolic associated fatty liver disease (MAFLD) is becoming increasingly prevalent in China. Identifying patients at high risk of fibrosis is crucial for clinical management. This study aimed to assess the dynamic Fibrosis-4 (FIB-4) trajectory and its association with cardiovascular-cerebrovascular events (CCEs) and explore the progression of fibrosis in patients with MAFLD. METHODS AND RESULTS: This retrospective analysis included adult patients with at least three records who underwent physical examination between January 2017 and December 2023. A latent class mixed model (LCMM) was used to fit the FIB-4 trajectory. The multistate Markov model was applied to assess transitions in advanced liver fibrosis risk states. A total of 12,839 patients were analyzed, with 5777 MAFLD patients included in the final study. During a median follow-up of 46.2 months, CCEs occurred in 221 patients (3.83%). Based on the LCMM model, three trajectory groups were identified: Class 1 (low-stable), Class 2 (high-stable), and Class 3 (high-rising). In the multivariable-adjusted models, both class 2 and class 3 were significantly associated with the incidence of CCEs, with aHR (95% CI) of 2.73 (2.01-3.71) and 2.46 (1.25-4.86), respectively. Additionally, class 3 showed a rapid increase in FIB-4 at approximately 30 months. The multi-state Markov model indicated that the probability of high-risk of advanced liver fibrosis alleviating to medium-low risk was significantly higher than the probability of medium-low risk progressing to high risk. CONCLUSIONS: Monitoring FIB-4 trajectory aids in the early identification and intervention of high-risk MAFLD patients, potentially preventing irreversible fibrosis and reducing CCEs risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisCardiovascular DiseasesNon-alcoholic Fatty Liver DiseaseCerebrovascular DisordersDecision Support TechniquesHumansDisease ProgressionMarkov ChainsFemaleMiddle AgedRetrospective StudiesRisk AssessmentMaleTime FactorsAdultPredictive Value of TestsPrognosisChinaAgedRisk FactorsIncidenceBiomarkers

Stichwörter der Autor:innen

Cardiovascular-cerebrovascular eventsFIB-4 trajectoryLiver fibrosis progressionMetabolic associated fatty liver diseaseMulti-state Markov model

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Gastroenterology, Taizhou Hospital of Zhejiang Province, Linhai, Zhejiang, China; Dalian Medical University, Dalian, China.
  • Affiliated Hospital of Jiaxing University(The First Hospital of Jiaxing), Jiaxing, Zhejiang, China.
  • Department of Gastroenterology, Taizhou Hospital of Zhejiang Province, Linhai, Zhejiang, China.
  • Health Management Center, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China.
  • Department of Thoracic Surgery, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China.
  • Health Management Center, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China. Electronic address: chenyh@enzemed.com.

Förderung

  • Science and Technology Plan Project of Taizhou
  • Medical Science and Technology Project of Zhejiang Province

Zitieren

APA

Fu, X. Y., Yan, S. Y., Song, Y. Q., Ye, Y. F., Ma, J. L., Yan, L. L., Liang, J. W., Xu, S. J., Xu, S. W., Chen, Y. H., Mao, X. L., & Li, S. W. (2026). Dynamic FIB-4 trajectory and a multi-state Markov model analysis reveal fibrosis progression and cardiovascular-cerebrovascular risk in MAFLD patients. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2026.104617

Vancouver

Fu XY, Yan SY, Song YQ, Ye YF, Ma JL, Yan LL, et al. Dynamic FIB-4 trajectory and a multi-state Markov model analysis reveal fibrosis progression and cardiovascular-cerebrovascular risk in MAFLD patients. Nutrition, Metabolism and Cardiovascular Diseases. 2026. doi:10.1016/j.numecd.2026.104617

BibTeX
@article{Fu2026,
  author = {Fu, Xin-Yu and Yan, Si-Yan and Song, Ya-Qi and Ye, Ya-Fei and Ma, Jia-Li and Yan, Ling-Ling and Liang, Jia-Wei and Xu, Shan-Jing and Xu, Shi-Wen and Chen, Ya-Hong and Mao, Xin-Li and Li, Shao-Wei},
  title = {Dynamic FIB-4 trajectory and a multi-state Markov model analysis reveal fibrosis progression and cardiovascular-cerebrovascular risk in MAFLD patients},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2026},
  doi = {10.1016/j.numecd.2026.104617}
}
Kostenlos starten →